학술논문

Corrigendum to “Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase” [Antivir. Res. 218 (2023) 105716–105728, doi: 10.1016/j.antiviral.2023.105716] (Antiviral Research (2023) 218, (S0166354223001948), (10.1016/j.antiviral.2023.105716))
Document Type
Erratum
Source
In: Antiviral Research. (Antiviral Research, November 2023, 219)
Subject
Language
English
ISSN
18729096
01663542